Search research articles
Contact Us
Filters
Showing results (181-190 of 256) with videos related to
Page
of 26
Sort By:
The American Journal of Clinical Nutrition
|
March 6, 2021
Distribution and metabolism of [14C]-resveratrol in human prostate tissue after oral administration of a "dietary-achievable" or "pharmacological" dose: what are the implications for anticancer activity?
Hong Cai, Edwina N Scott, Robert G Britton, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
October 22, 2013
Cellular and plasma uptake of parenteral omega-3 rich lipid emulsion fatty acids in patients with advanced pancreatic cancer
A Arshad, W Y Chung, J Isherwood, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 20, 2007
The use of pharmacokinetic and pharmacodynamic end points to determine the dose of AQ4N, a novel hypoxic cell cytotoxin, given with fractionated radiotherapy in a phase I study
W P Steward, M Middleton, A Benghiat, et al.
Rapid Communications in Mass Spectrometry : RCM
|
December 10, 2008
Simultaneous determination of 8-oxo-2'-deoxyguanosine and 8-oxo-2'-deoxyadenosine in DNA using online column-switching liquid chromatography/tandem mass spectrometry
Rajinder Singh, Friederike Teichert, Richard D Verschoyle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 14, 2008
Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases
C P Neal, C D Mann, C D Sutton, et al.
Journal of Pain and Symptom Management
|
August 30, 2008
Patient-reported outcomes as a component of the primary endpoint in a double-blind, placebo-controlled trial in advanced pancreatic cancer
S Gail Eckhardt, Peter De Porre, David Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice
Mark J Anderton, Margaret M Manson, Richard D Verschoyle, et al.
Seminars in Oncology
|
February 1, 1992
Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma Group
G Blackledge, W P Steward, J Verweij, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 18, 2011
Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics
Lynne M Howells, D P Berry, P J Elliott, et al.
Cancer Letters
|
December 22, 2007
Androgen manipulation alters oxidative DNA adduct levels in androgen-sensitive prostate cancer cells grown in vitro and in vivo
Sanjeev Pathak, Rajinder Singh, Richard D Verschoyle, et al.
Page
of 26
Search research articles
Search
Showing results (181-190 of 256) with videos related to
Sort By:
Page
of 26
The American Journal of Clinical Nutrition
|
March 6, 2021
Distribution and metabolism of [14C]-resveratrol in human prostate tissue after oral administration of a "dietary-achievable" or "pharmacological" dose: what are the implications for anticancer activity?
Hong Cai, Edwina N Scott, Robert G Britton, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
October 22, 2013
Cellular and plasma uptake of parenteral omega-3 rich lipid emulsion fatty acids in patients with advanced pancreatic cancer
A Arshad, W Y Chung, J Isherwood, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 20, 2007
The use of pharmacokinetic and pharmacodynamic end points to determine the dose of AQ4N, a novel hypoxic cell cytotoxin, given with fractionated radiotherapy in a phase I study
W P Steward, M Middleton, A Benghiat, et al.
Rapid Communications in Mass Spectrometry : RCM
|
December 10, 2008
Simultaneous determination of 8-oxo-2'-deoxyguanosine and 8-oxo-2'-deoxyadenosine in DNA using online column-switching liquid chromatography/tandem mass spectrometry
Rajinder Singh, Friederike Teichert, Richard D Verschoyle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 14, 2008
Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases
C P Neal, C D Mann, C D Sutton, et al.
Journal of Pain and Symptom Management
|
August 30, 2008
Patient-reported outcomes as a component of the primary endpoint in a double-blind, placebo-controlled trial in advanced pancreatic cancer
S Gail Eckhardt, Peter De Porre, David Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice
Mark J Anderton, Margaret M Manson, Richard D Verschoyle, et al.
Seminars in Oncology
|
February 1, 1992
Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma Group
G Blackledge, W P Steward, J Verweij, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 18, 2011
Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics
Lynne M Howells, D P Berry, P J Elliott, et al.
Cancer Letters
|
December 22, 2007
Androgen manipulation alters oxidative DNA adduct levels in androgen-sensitive prostate cancer cells grown in vitro and in vivo
Sanjeev Pathak, Rajinder Singh, Richard D Verschoyle, et al.
Page
of 26